MA46972A - Forme polymorphe de sépiaptérine - Google Patents

Forme polymorphe de sépiaptérine

Info

Publication number
MA46972A
MA46972A MA046972A MA46972A MA46972A MA 46972 A MA46972 A MA 46972A MA 046972 A MA046972 A MA 046972A MA 46972 A MA46972 A MA 46972A MA 46972 A MA46972 A MA 46972A
Authority
MA
Morocco
Prior art keywords
sepiapterin
polymorphic form
polymorphic
Prior art date
Application number
MA046972A
Other languages
English (en)
Inventor
Kaito Kishimoto
Taichi Komoda
Daniel E Levy
Takayoshi Matsumoto
Shunichi Murata
Yuichi Shiro
Hiroshi Yoshino
Original Assignee
Censa Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Censa Pharmaceuticals Inc filed Critical Censa Pharmaceuticals Inc
Publication of MA46972A publication Critical patent/MA46972A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA046972A 2016-11-29 2017-11-28 Forme polymorphe de sépiaptérine MA46972A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662427686P 2016-11-29 2016-11-29

Publications (1)

Publication Number Publication Date
MA46972A true MA46972A (fr) 2019-10-09

Family

ID=62241955

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046972A MA46972A (fr) 2016-11-29 2017-11-28 Forme polymorphe de sépiaptérine

Country Status (8)

Country Link
US (2) US11130760B2 (fr)
EP (1) EP3548487A4 (fr)
JP (1) JP7148532B2 (fr)
CN (1) CN110312721A (fr)
CA (1) CA3043499A1 (fr)
MA (1) MA46972A (fr)
MX (1) MX2019006207A (fr)
WO (1) WO2018102314A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5066756B2 (ja) 2010-04-22 2012-11-07 学校法人日本大学 脳機能障害予防・改善用の薬剤及び飲食物
CN116903624A (zh) 2016-11-29 2023-10-20 Ptc医疗Mp公司 墨蝶呤及其盐的多晶型物
MX2020002271A (es) 2017-09-01 2020-10-05 Ptc Therapeutics Mp Inc Composiciones farmaceuticas que comprenden sepiapterina y sus usos de las mismas.
CN112703002A (zh) 2018-05-30 2021-04-23 Ptc医疗Mp公司 增加墨蝶呤血浆暴露的方法
EP3807279A4 (fr) * 2018-05-30 2022-04-06 PTC Therapeutics MP, Inc. Sels pharmaceutiquement acceptables de sépiaptérine
US20220273661A1 (en) 2019-08-05 2022-09-01 Ptc Therapeutics Mp, Inc. Use of sepiapterin and metabolites thereof to treat radiation exposure
MX2022003585A (es) 2019-09-25 2022-04-19 Ptc Therapeutics Mp Inc Metodos para tratar hiperfenilalaninemia.
WO2021150983A1 (fr) 2020-01-24 2021-07-29 Ptc Therapeutics Mp, Inc. Méthodes de traitement de la maladie de parkinson avec de la sépiaptérine
JP2024506336A (ja) 2021-02-09 2024-02-13 ピーティーシー セラピューティクス エムピー，インコーポレイテッド 膠芽腫の治療方法
EP4291196A1 (fr) 2021-02-09 2023-12-20 PTC Therapeutics MP, Inc. Procédés de traitement de la covid-19 avec de la sépiaptérine
IL311716A (en) * 2021-09-29 2024-05-01 Ptc Therapeutics Inc Pharmaceutical compositions of Spiafetrin

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925323A (ja) * 1982-03-03 1984-02-09 鐘淵化学工業株式会社 プテリン誘導体からなる脳内神経伝達物質の関わる疾病の治療剤
AU727445B2 (en) 1995-08-18 2000-12-14 Donald W Landry Detection of organic compounds through regulation of antibody-catalyzed reactions
US8188043B2 (en) 1999-07-28 2012-05-29 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
FR2859996B1 (fr) 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
RU2434870C2 (ru) 2003-11-17 2011-11-27 Мерк Эпрова Аг Кристаллические формы дигидрохлорида (6r)-l-эритро-тетрагидробиоптерина
EP1776364A2 (fr) 2003-11-17 2007-04-25 BioMarin Pharmaceutical Inc. Procedes de preparation de tetrahydrobiopterine et d'analogues de la tetrahydrobiopterine
DK1708690T3 (en) 2003-11-17 2016-11-07 Biomarin Pharm Inc TREATMENT OF PHENYLKETONURI WITH BH4
EP2436379A1 (fr) 2004-11-17 2012-04-04 BioMarin Pharmaceutical Inc. Formule de comprimé stable
EP1819340A2 (fr) 2004-12-08 2007-08-22 Biomarin Pharmaceutical Inc. Methodes et compositions de traitement de l'hypertension pulmonaire du nouveau-ne
DK1877370T3 (da) 2005-04-28 2009-05-11 Shiratori Pharm Fremgangsmåde til fremstilling af hydrazon-derivater
US20080075666A1 (en) 2006-08-25 2008-03-27 Dudley Samuel C Jr Methods and compositions for treating diastolic dysfunction
EP2139485B1 (fr) 2007-04-11 2012-10-17 BioMarin Pharmaceutical Inc. Procédés d'administration de la tétrahydrobioptérine, compositions associées et procédés de mesure
PL2309983T3 (pl) 2008-08-12 2019-09-30 Orpha Swiss Gmbh Farmaceutyczna postać podawania zawierająca tetrahydrobiopterynę
JP5066756B2 (ja) 2010-04-22 2012-11-07 学校法人日本大学 脳機能障害予防・改善用の薬剤及び飲食物
US9884909B2 (en) 2010-12-01 2018-02-06 Alderbio Holdings Llc Anti-NGF compositions and use thereof
RU2017134002A (ru) 2011-03-01 2019-02-07 Дифарма С.А. Стабильные композиции тетрагидробиоптерина
US9216178B2 (en) * 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
US9181254B2 (en) * 2012-05-07 2015-11-10 Shiratori Pharmaceutical Co., Ltd. Method for producing sepiapterin and tetrahydrolactoylpterin
CN116903624A (zh) 2016-11-29 2023-10-20 Ptc医疗Mp公司 墨蝶呤及其盐的多晶型物
MX2020002271A (es) 2017-09-01 2020-10-05 Ptc Therapeutics Mp Inc Composiciones farmaceuticas que comprenden sepiapterina y sus usos de las mismas.

Also Published As

Publication number Publication date
US20220081443A1 (en) 2022-03-17
US11130760B2 (en) 2021-09-28
EP3548487A4 (fr) 2020-04-29
CN110312721A (zh) 2019-10-08
CA3043499A1 (fr) 2018-06-07
US20200010469A1 (en) 2020-01-09
EP3548487A1 (fr) 2019-10-09
JP7148532B2 (ja) 2022-10-05
MX2019006207A (es) 2019-11-18
WO2018102314A1 (fr) 2018-06-07
JP2020500931A (ja) 2020-01-16

Similar Documents

Publication Publication Date Title
MA46972A (fr) Forme polymorphe de sépiaptérine
DK3180331T3 (da) Polymorfer af selinexor
IL263050B (en) History of Subtirum
DK3558995T3 (da) Polymorfer
DK3191406T3 (da) Fremgangsmåde til fremstilling af aluminiumchloridderivater
DK3558961T3 (da) Polymorfer
IL292245A (en) Polymorphic forms of rad1901–2hcl
IL272697A (en) A polymorphic form of TG02
IT201600130313A1 (it) Struttura portante di veicolo
DK3373931T3 (da) Heterocykliske forbindelser til behandling af sygdom
FR3023290B1 (fr) Derives de flavaglines
DK3302573T3 (da) Sammensætning til behandlingen af hjernelæsioner
DK3180314T3 (da) Fremgangsmåde til fremstilling af syntetiske mellemprodukter til fremstilling af tetrahydroquinolin-derivater
DK3430004T3 (da) Faststofformer af nilotinibsalte
MA46266A (fr) Formes cristallines
DK3515454T3 (da) Krystallinsk polymorf form af 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2lambda5-[1,2]oxaphosphinan
MA48944A (fr) Forme cristalline de n-butyldéoxygalactonojirimycine
ITUA20161550A1 (it) Procedimento per la produzione di RNA
MA41641A (fr) Dérivés de tétrahydropyranylbenzamide
ITUB20169994A1 (it) Nuove forme cristalline di farmaci immunomodulatori
FR3039391B1 (fr) Orthese de contention
IT201700025286A1 (it) Forme cristalline di vinpocetina cloridrato
MA49558A (fr) Dérivativés de 2-oxo-1-imidazolidinyl imidazothiadiazole
UA34108S (uk) Ковдра
UA34109S (uk) Ковдра